The effect of Oxytocin on Vaginal Atrophy and Sexual Function in Post-menopausal Wome
Phase 3
Recruiting
- Conditions
- Vaginal atrophy and sexual function of postmenopausal women.Postmenopausal atrophic vaginitis
- Registration Number
- IRCT20160602028220N2
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 96
Inclusion Criteria
Have reading and writing skills
Women aged 40-60
Passing for at least one year from the last menstruation or having a hormonal test with FSH of more than 40 international units
The presence of vaginal atrophy
Sexual performance score less than or equal to 26/5
Have sex and monogamy
Exclusion Criteria
vaginal infection
Treatment with HRT or taking sex hormones during 8 weeks before study
Any major disease genital
Consuming Smoking, alcohol or any opiate
Uterine bleeding and spotting
Body mass index more than 30
Breast disease with unknown cause
Use of vaginal drugs or any lubricant for at least 15 days before the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptoms of vaginal atrophy. Timepoint: At the beginning of the intervention and 14 and 56 days after the start of the intervention. Method of measurement: The combined questionnaire vaginal atrophy symptoms.;The percentage of the maturity of the cells of the vagina. Timepoint: before and after intervention. Method of measurement: Vaginal smears.;The acidity of the vagina. Timepoint: before and after intervention. Method of measurement: PH strip.
- Secondary Outcome Measures
Name Time Method Sexual function. Timepoint: before and after intervention. Method of measurement: Female sexual function index questionnaire.